» Articles » PMID: 38019761

BushenHuoxue Formula Promotes Osteogenic Differentiation Via Affecting Hedgehog Signaling Pathway in Bone Marrow Stem Cells to Improve Osteoporosis Symptoms

Overview
Journal PLoS One
Date 2023 Nov 29
PMID 38019761
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The BushenHuoxue formula (BSHX) has been previously demonstrated to ameliorate osteoporosis, but the mechanisms underlying this phenomenon are currently unclear. The present study aims at investigating the mechanisms that BSHX induces osteogenesis.

Methods: We established an osteoporosis model in rats by bilateral ovariectomy and then treated the rats with an osteogenic inducer (dexamethasone, β-sodium glycerophosphate and Vitamin C) and BSHX. After that, bone marrow density and histopathological bone examination were evaluated by using HE staining and immunohistochemistry, respectively. We also assessed the differentiation of bone marrow mesenchymal stem cells (BMSCs) into osteoblasts by using immunofluorescence staining. ALP, BMP, and COL1A1 levels were determined by ELISA. We identified genes involved in pathogenesis of osteoporosis through Gene Expression Omnibus (GEO) database and subsequently selected Hedgehog signaling-related genes Shh, Ihh, Gli2, and Runx2 for assessment via qRT-PCR and ELISA, Western blotting. Network pharmacology analysis was performed to identify bioactive metabolites of BSHX.

Results: BSHX treatment in osteoporosis model rats promoted tightening of the morphological structure of the trabecular bone and increased the bone mineral density (BMD). BSHX also increased levels of osteoblast makers ALP, BMP, and COL1A1. Additionally, bioinformatics analysis of the GEO dataset showed that Hedgehog signaling pathway was involved in pathogenesis of osteoporosis, especially related genes Shh, Ihh, Gli2, and Runx2. Remarkably, BHSX upregulated these genes indispensably involved in the osteogenesis-related Hedgehog signaling pathway in both bone tissue and BMSCs. Importantly, we identified that quercetin was the active compounds that involved in the mechanism of BSHX-improved OP via affecting Hedgehog-related genes.

Conclusion: Our results indicate that BSHX promotes osteogenesis by improving BMSC differentiation into osteoblasts via increased expression of Hedgehog signaling-related genes Shh, Ihh, Gli2, and Runx2, and quercetin was the bioactive compound of BSHX.

Citing Articles

LINC01133 promotes the osteogenic differentiation of bone marrow mesenchymal stem cells by upregulating CTNNB1 by acting as a sponge for miR-214-3p.

Tang C, Huang L, Guo X, Wang G, Chen Z J Orthop Surg Res. 2024; 19(1):572.

PMID: 39285416 PMC: 11406849. DOI: 10.1186/s13018-024-05053-8.


CRYAB suppresses ferroptosis and promotes osteogenic differentiation of human bone marrow stem cells via binding and stabilizing FTH1.

Tian B, Li X, Li W, Shi Z, He X, Wang S Aging (Albany NY). 2024; 16(10):8965-8979.

PMID: 38787373 PMC: 11164484. DOI: 10.18632/aging.205851.

References
1.
Jemtland R, Divieti P, Lee K, Segre G . Hedgehog promotes primary osteoblast differentiation and increases PTHrP mRNA expression and iPTHrP secretion. Bone. 2003; 32(6):611-20. DOI: 10.1016/s8756-3282(03)00092-9. View

2.
Peng Z, Xu R, You Q . Role of Traditional Chinese Medicine in Bone Regeneration and Osteoporosis. Front Bioeng Biotechnol. 2022; 10:911326. PMC: 9194098. DOI: 10.3389/fbioe.2022.911326. View

3.
Beloti M, Bellesini L, Rosa A . Purmorphamine enhances osteogenic activity of human osteoblasts derived from bone marrow mesenchymal cells. Cell Biol Int. 2005; 29(7):537-41. DOI: 10.1016/j.cellbi.2005.02.007. View

4.
Gersbach C, Byers B, Pavlath G, Garcia A . Runx2/Cbfa1 stimulates transdifferentiation of primary skeletal myoblasts into a mineralizing osteoblastic phenotype. Exp Cell Res. 2004; 300(2):406-17. DOI: 10.1016/j.yexcr.2004.07.031. View

5.
Aljohani S, Fliefel R, Ihbe J, Kuhnisch J, Ehrenfeld M, Otto S . What is the effect of anti-resorptive drugs (ARDs) on the development of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: A systematic review. J Craniomaxillofac Surg. 2017; 45(9):1493-1502. DOI: 10.1016/j.jcms.2017.05.028. View